Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
MarsBio is an early-stage biotechnology investment fund founded around 2019-2020, based in Los Angeles, California. The firm focuses on supporting scientists and engineers in building impactful businesses that leverage biotechnology for societal transformation. MarsBio aims to advance the field of biotechnology by investing in innovative ventures that address critical global challenges.
The organization has a strong commitment to early-stage investments, primarily targeting pre-seed, seed, and seed-plus stages. MarsBio's portfolio currently includes 10 companies, showcasing its dedication to fostering groundbreaking solutions in biotechnology. The fund has garnered notable support, including a $15 million matching fund loan from LA County to enhance its investment capabilities in bioscience startups.
As of now, MarsBio operates with a team of experienced professionals, including general partners and advisors with deep expertise in biotechnology. The firm continues to evolve, actively promoting its mission and portfolio through its website and various media appearances.
MarsBio invests in a diverse range of sectors within biotechnology, including synthetic biology, therapeutics, materials science, agriculture, and consumer goods. The firm seeks to back bold bioscience entrepreneurs at the earliest stages of their ventures, providing them with essential resources and support to succeed. The check sizes typically range from $250,000 to $500,000, allowing MarsBio to engage with startups effectively.
The investment thesis emphasizes supporting relentless founders with uncompromising visions for the future of biology. MarsBio focuses on using biology as a manufacturing tool, which aligns with its commitment to advancing innovative solutions in health and environmental technologies. The firm actively seeks opportunities to invest in companies that are developing novel health and environmental technologies, thereby contributing to significant advancements in the biotechnology sector.
MarsBio's portfolio includes a variety of innovative companies that are making strides in biotechnology:
Rob Rhinehart is a co-founder and general partner, known for creating Soylent and transitioning from bioscience entrepreneur to investor. Arye Lipman serves as a co-founder and general partner, previously co-founding BioBuilt, an advisory firm for biotech startups. Llewellyn Cox, also a co-founder and general partner, has a strong operational background in biotech, having co-founded BioBuilt as well.
Founders can pitch MarsBio through their website at marsbio.vc. It's important to include a clear vision of how the startup addresses significant challenges in biotechnology.
What types of companies does MarsBio invest in?
MarsBio focuses on early-stage biotechnology ventures across sectors like synthetic biology, therapeutics, and agtech.
What is the typical investment size?
The firm typically invests between $250,000 and $500,000 in its portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.